RESULTS OF GLYCEMIC CONTROL IN NEONATAL DEABETES MELLITUS ATNATIONAL CHILDREN’S HOSPITAL
Main Article Content
Abstract
Glycemic control (GC) is the primary goal for the regulation and management of diabetes. Good glycemic control for children with neonatal diabetes mellitus (NDM) helps prevent complications. Objectives: Review the results of GC in NDM children at the National Children's Hospital. Method: Cases series report. Results: 94.1% of patients carrying ABCC8/KCNJ11 mutations achieved good GC levels when treated with SU, one patient with undetected mutant genes treated with SU had good baseline blood glucose levels, when converted to insulin had good blood glucose levels but poor HbA1c. When treated with insulin, 37.5% (HbA1c-based) and 25% (blood-glucose-based) patients with other gene mutations reached the GMG target. 2/7 patients without genetic mutations were stopped but had to restart insulin during acute infections. 100% of patients with 6q24 abnormality had a good GC before stopping the drug, no patients had relapsed. There were no patients with severe hypoglycaemia, asymptomatic hypoglycaemia was seen mainly in insulin-treated patients.
Article Details
Keywords
Neonatal diabetes mellitus, lycemic control, `, insulin, sulfonylurea
References
2. Rewers MJ, Pillay K, de Beaufort C, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15 Suppl 20:102-114. doi:10.1111/pedi.12190
3. Cao B, Gong C, Wu D, et al. Genetic Analysis and Follow-Up of 25 Neonatal Diabetes Mellitus Patients in China. J Diabetes Res. 2016;2016:6314368. doi:10.1155/2016/6314368
4. Tran F, Vu DC, Nguyen HT, et al. Glycaemic control in children with neonatal diabetes and type 1 diabetes in Vietnam. Int Health. 2011;3(3):188-192. doi:10.1016/j.inhe.2011.03.008
5. Rafiq M, Flanagan SE, Patch A-M, et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care. 2008; 31(2):204-209. doi:10.2337/dc07-1785
6. Cấn Thị Bích Ngọc. Nghiên cứu đột biến gen, lâm sàng và điều trị bệnh đái tháo đường sơ sinh.Luận văn tiến sỹ y học, Đại học Y Hà Nội
7. Zhang M, Chen X, Shen S, et al. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds. J Pediatr Endocrinol Metab. 2015;28(7-8):877-884. doi:10.1515/jpem-2014-0429
8. Flanagan SE, Mackay DJG, Greeley SAW, et al. Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects – expanding the clinical phenotype. Diabetologia. 2013; 56(1):218-221. doi:10.1007/s00125-012-2766-z